Stay updated on Pediatric Cabozantinib Clinical Trial
Sign up to get notified when there's something new on the Pediatric Cabozantinib Clinical Trial page.

Latest updates to the Pediatric Cabozantinib Clinical Trial page
- Check5 days agoChange DetectedInternal site version updates were applied: revision v3.5.2 was added on 2026-04-09 and 2026-04-13, and revision v3.5.0 was removed on 2026-04-07 and 2026-04-08.SummaryDifference0.1%

- Check12 days agoChange DetectedAdministrative updates added on 2026-04-07 and 2026-04-08 and deletions on 2026-04-01 and 2026-03-31, reflecting page metadata edits.SummaryDifference0.1%

- Check19 days agoChange DetectedMedullary thyroid carcinoma and adrenal cortex carcinoma were added to the list of conditions. Deletions occurred on 2026-03-24 and 2026-03-25.SummaryDifference0.1%

- Check26 days agoChange Detected**Release log update:** Added entries for 2026-03-25 and 2026-03-24 and updated to Revision v3.5.0. Removed entries for 2026-03-17 and 2026-03-14 with the previous Revision v3.4.3.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded Rhabdomyosarcoma and Hepatocellular carcinoma to the condition list. Removed entries on 2026-03-07 and 2026-03-10.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision notes updated to include v3.4.3 with dates 2026-03-07 and 2026-03-10. Legacy entry v3.4.2 was removed (dates 2026-02-11 and 2026-03-03).SummaryDifference0.1%

Stay in the know with updates to Pediatric Cabozantinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Cabozantinib Clinical Trial page.